Valeant Pharmaceuticals International VRX
The three reasons
- 1
Citron's 'next Enron' channel-stuffing claim is verifiably false; Philidor accounting is conservative
- 2
Even zeroing out Philidor, VRX trades at ~8x 2016 Cash EPS with 15% organic growth YTD
- 3
Like AmEx after the 1963 Salad Oil Scandal, the franchise is resilient and the dislocation is a buying opportunity
Primary demands
- Valeant should terminate the Philidor relationship and develop new specialty-pharmacy channel partners
- Valeant must dramatically increase transparency around its specialty pharmacy strategy
- Ad hoc board committee should complete Philidor compliance review and publish findings
- Valeant should invest in public, government and investor relations to match business complexity
KPIs cited
Pattern membership
Where this document fits across the library's 12 rhetorical / structural patterns.
Notable slides (7)
Notes
Third Pershing Square deck on Valeant, delivered October 30, 2015 at the peak of the Philidor scandal. Unusual specimen: an activist defending an existing long position during a short-seller attack (Citron's 'next Enron' report, 10/21/15) rather than mounting a new attack. Structure follows a defensive SCQA: (1) context on VRX strategy and transparency deficit under CEO Mike Pearson, (2) annotated share-price timelines documenting the crisis, (3) detailed refutation of the R&O/Russell Reitz narrative via court filings and email evidence, (4) Novartis specialty-pharmacy kickback case as a precedent showing even large fraud settlements need not destroy the business, (5) three unanswered questions Pershing still holds VRX management to, (6) floor-case valuation showing stock is cheap even if Philidor is zeroed, (7) closing analogy to AmEx's 1963 Salad Oil Scandal with a young Buffett buying the dip, plus the 'be fearful when others are greedy' quote. Rhetorical move worth studying: the deck concedes Valeant's failings (opacity, underinvestment in PR/IR, costly mistakes) to buy credibility before defending the franchise. Side-by-side supply-chain diagram (p12) and Philidor/R&O corporate timelines (p14, 15) are the most citation-worthy visuals. Campaign ultimately failed badly — Philidor was shut down days later, Pearson was later replaced, and Pershing Square exited VRX in March 2017 at an estimated ~$4bn realized loss. This deck is now a frequently-cited case study in activist overconfidence and sunk-cost escalation.